VISTAAR added more AI capabilities to Clinical Insights
05/02/2020

Clinical trial intelligence and insights from VISTAAR enables clinical teams to find deeper insights to design and plan clinical trials better

Online PR News – 02-May-2020 – United states – Continuing the legacy of bringing “context” based solutions to industry, VISTAAR adds deeper AI capabilities to its “ClinIntel” module to support Pharmaceutical, Biotech, Medical Device companies as well CROs. VISTAAR with its ever-growing clinical data sets, one of the key challenges had been on getting the right answers quickly from its internal diverse data.

When a user knows what exactly they are looking for, ClinIntel provides straight search options. But if the answers need multi-data set analysis with multiple conditions, users leverage AI search

Clinical Scientists or medical teams while planning a study or optimizing a design or protocol assessment, the search and screens are laid out from their perspective to help them get different scenarios data much faster for them to analyze and plan their next steps

For Clinical operations teams, searches are positioned for them to search countries, investigators, sites details for them to pick right sets for better selection as this is key for study success
Also, users can leverage clinical insights that run across multiple countries in clinical studies.

About VISTAAR:

VISTAAR is most up-to-date compared to any other Tool or Data source because we use smart artificial intelligence methods throughout. With a unique combination of technology and smart people, you will get your strategy and trusted insights much faster. Over many years, VISTAAR has built deep and diverse data sets to help you or your Regulatory and Clinical projects. All this is done at the best price point in the industry. Visit us for more information https://www.vistaar.ai/